BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $394,000 | -20.9% | 7,800 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $498,000 | +86.5% | 7,800 | +200.5% | 0.01% | +71.4% |
| Q3 2021 | $267,000 | +1.9% | 2,596 | -12.7% | 0.01% | -12.5% |
| Q2 2021 | $262,000 | +12.4% | 2,975 | +24.1% | 0.01% | -11.1% |
| Q1 2021 | $233,000 | -87.7% | 2,398 | -90.1% | 0.01% | -93.1% |
| Q2 2020 | $1,894,000 | +310.0% | 24,283 | +395.6% | 0.13% | +209.5% |
| Q2 2019 | $462,000 | -5.5% | 4,900 | -19.7% | 0.04% | -10.6% |
| Q1 2019 | $489,000 | +22.6% | 6,104 | -17.5% | 0.05% | -19.0% |
| Q4 2018 | $399,000 | -12.3% | 7,401 | +27.1% | 0.06% | +28.9% |
| Q3 2018 | $455,000 | -74.8% | 5,823 | -87.1% | 0.04% | -86.6% |
| Q1 2017 | $1,808,000 | – | 45,200 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |